Researchers have identified two FDA-approved cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s-related brain ...

Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an inflammatory ...

Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping scientists identify stronger targets, predict outcomes earlier, and reshape ...

OpenAI published a substantial update to GPT-Rosalind on June 3, 2026, deepening the domain-specialized model's performance across drug discovery, genomics, and wet-lab research — and opening the ...

AI life science benchmark LifeSciBench, published June 17 by OpenAI with 173 PhD scientists, shows frontier models clear only ...

Lipid metabolism and organelle communication have emerged as central regulators of immune function and tumor progression. Within tumor-associated ...

Keratinocytes, which activate an EMT-like program in the skin, can prevent melanoma invasion, highlighting how changes in the tumor microenvironment can act as restraining forces in cancer.

Precision medicine is advancing rapidly, but access remains limited. Experts highlight unmet needs, how science is translated ...

There’s truth to the old adage, “Age is just a number.” People of the same age differ vastly in health and mental capabilities. One 80-year-old may be vibe coding with Claude, while another is ...

The field of cancer immunotherapy has reshaped modern oncology, with immune checkpoint inhibitors and cellular therapies producing unprecedented and durable ...